date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-19-18,"The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke",Zacks
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,AstraZeneca to Present New Data Demonstrating Breadth of Research Portfolio in Renal Disease at ASN Kidney Week 2018,Business Wire
Oct-23-18,[$$] AstraZeneca Adds Cancer Drugs to Pipeline,The Wall Street Journal
Oct-23-18,AstraZeneca digs deeper into cancer with Innate stake,Reuters
Oct-23-18,[$$] AstraZeneca deepens partnership with Innate Pharma,Financial Times
Oct-23-18,AstraZeneca to buy 9.8 percent stake in France's Innate Pharma,Reuters
Oct-24-18,Here's Why Tesaro Inc. Dropped 13.8% Today,Motley Fool
Oct-25-18,Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company,ACCESSWIRE
Oct-25-18,[$$] The London Report: dollar earners buoy FTSE 100,Financial Times
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-30-18,"AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal",Reuters
Oct-30-18,[$$] European Corporate Roundup,The Wall Street Journal
Oct-30-18,[$$] AstraZeneca to Sell Drugs Rights for $815M,The Wall Street Journal
Nov-01-18,European businesses demand urgent Brexit deal after meeting May,Reuters
Nov-01-18,The Landmark DECLARE-TIMI 58 Cardiovascular Outcomes Trial of FARXIGA in Patients with Type 2 Diabetes to Be Featured at AHA 2018,Business Wire
Nov-02-18,"Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus",Zacks
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,BMY vs. AZN: Which Stock Is the Better Value Option?,Zacks
Nov-06-18,"Cheplapharm Arzneimittel GmbH -- Moody's affirms Cheplapharm's B1 CFR, assigns B1 to term loan add-on, stable outlook",Moody's
Nov-06-18,Today's Research Reports on Trending Tickers: AbbVie and AstraZeneca,ACCESSWIRE
Nov-06-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-06-18,[$$] AstraZeneca sells trio of respiratory drugs for $350m,Financial Times
Nov-06-18,"AstraZeneca sells older asthma, rhinitis drugs for $350 million",Reuters
Nov-06-18,"AstraZeneca sells older asthma, rhinitis drugs for $350 mln",Reuters
Nov-07-18,Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer,GlobeNewswire
Nov-07-18,Astrazeneca Q3 Earnings Preview,Benzinga
Nov-08-18,AstraZeneca Breaks Out As CEO Predicts 'Sustained Growth' Streak,Investor's Business Daily
Nov-08-18,AstraZeneca lifts FTSE as U.S. midterm rally fades,Reuters
Nov-08-18,AstraZeneca chief says the US drugs market is under pressure and changes are coming,CNBC
Nov-08-18,AstraZeneca sees years of growth as drug sales turn corner,Reuters
Nov-08-18,"AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales",Zacks
Nov-08-18,Astrazeneca: 3Q Earnings Snapshot,Associated Press
Nov-08-18,AstraZeneca sees years of growth as drug sales turn corner,Reuters
Nov-08-18,[$$] AstraZeneca 3Q Sales Increased on New Drug Performance,The Wall Street Journal
Nov-08-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-08-18,AstraZeneca has finally delivered its four-year objective...,CNBC Videos
Nov-08-18,"AstraZeneca returns to sales growth, led by cancer medicines",CNBC
Nov-08-18,"AstraZeneca returns to sales growth, led by cancer medicines",Reuters
Nov-08-18,[$$] AstraZeneca: back from the abyss,Financial Times
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-09-18,Today's Research Reports on Trending Tickers: AstraZeneca and Bristol-Myers Squibb,ACCESSWIRE
Nov-09-18,[$$] Opinion today: Europes plan for Donald Trump,Financial Times
Nov-12-18,"US FDA Accepts Regulatory Submission For LYNPARZA (olaparib) Maintenance Therapy in Newly-Diagnosed, BRCA-mutated Advanced Ovarian Cancer and Grants Priority Review",Business Wire
Nov-13-18,AstraZeneca's Lynparza Gets Priority Review in 1st Line Use,Zacks
Nov-13-18,This Recent Big Pharma Breakout Spiked Again On A $1.5 Billion Deal,Investor's Business Daily
Nov-13-18,$1.5B deal: AstraZeneca sells U.S. rights to respiratory medicine,American City Business Journals
Nov-13-18,AstraZeneca Keeps Pruning Drugs in $1.5 Billion Sale to Sobi,Bloomberg
Nov-13-18,[$$] European Corporate Roundup,The Wall Street Journal
Nov-13-18,Sobi buys rights to AstraZeneca infant drug for $1.5 bln upfront,Reuters
Nov-13-18,AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront,Reuters
Nov-14-18,AstraZeneca to Sell US Rights of Lung Infection Drug to Sobi,Zacks
Nov-14-18,"Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA",Zacks
Nov-14-18,AstraZeneca (AZN): Are Hedge Funds Right to be Bearish?,Insider Monkey
Nov-16-18,Stocks Slide At Open; This Dow Jones Name Bucks Chip Sell Off,Investor's Business Daily
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-16-18,AstraZeneca Shows It Can Still Take Some Knocks,Bloomberg
Nov-16-18,Is AstraZeneca PLC (LON:AZN) Excessively Paying Its CEO?,Simply Wall St.
Nov-16-18,AstraZenecas Lung Cancer Trial Fails to Meet Main Goal,Bloomberg
Nov-16-18,[$$] AstraZeneca Mystic lung cancer trial fails to deliver results,Financial Times
Nov-19-18,Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta,Zacks
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-20-18,Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails,Zacks
Nov-20-18,Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie,ACCESSWIRE
Nov-21-18,"Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up",Zacks
Nov-21-18,TESARO Shares Rally on Rumors of Potential Acquisition Offer,Zacks
Nov-21-18,Can Deal Interest Help Tesaro Recover?,Motley Fool
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,Read This Before You Buy AstraZeneca PLC (LON:AZN) Because Of Its P/E Ratio,Simply Wall St.
Nov-26-18,"The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca",Zacks
Nov-27-18,Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease,Zacks
Nov-27-18,AstraZeneca Presents Clinical Research Advances for Blood Cancer Patients at 2018 American Society of Hematology Annual Meeting,Business Wire
Nov-28-18,3 Top Dividend Stocks to Buy Right Now,Motley Fool
Nov-29-18,Biocartis partners with AstraZeneca on lung cancer diagnostics,Reuters
Nov-29-18,Biocartis partners with AstraZeneca on lung cancer diagnostics,Reuters
Nov-29-18,Biocartis Group NV: Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results,GlobeNewswire
Nov-29-18,AstraZeneca PLC (LON:AZN): The Best Of Both Worlds,Simply Wall St.
Dec-03-18,New Long-Term Data on CALQUENCE Presented at ASH 2018,Business Wire
Dec-03-18,"[$$] Stocks to watch: GSK, RPC, Stobart, Ted Baker, Bodycote, Tesaro",Financial Times
Dec-04-18,"Glaxo to Buy Zejula Maker TESARO for $5.1B, Stock Down 8%",Zacks
Dec-04-18,TESARO Shares Rally on Glaxo's $5.1 Billion Buyout Offer,Zacks
Dec-07-18,New Biotech IPO Dropped a Unicorn-Sized Value on Its First Day,Bloomberg
Dec-07-18,AstraZeneca's Imfinzi fails to meet main goals in head and neck cancer study,Reuters
Dec-11-18,"Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate",Benzinga
Dec-11-18,Moderna Stock Ushers In the Next Wave of Biotech,InvestorPlace
Dec-11-18,Can Moderna Stock Recover From Its Initial Setback?,Motley Fool
Dec-12-18,Here is What Hedge Funds Think About AstraZeneca plc (AZN),Insider Monkey
Dec-13-18,Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi,GlobeNewswire
Dec-13-18,Edited Transcript of AZN.L earnings conference call or presentation 26-Jul-18 11:30am GMT,Thomson Reuters StreetEvents
Dec-14-18,"Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",Zacks
Dec-17-18,Merck to Acquire Europe's Antelliq Group for $2.4 Billion,Zacks
Dec-17-18,Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases,PR Newswire
